Neural Therapeutics Inc. (NURL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 07/31
(Values in thousands)
| 07-2020 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 1,149 |
| Receivables | 200 |
| TOTAL | $1,349 |
| Non-Current Assets | |
| TOTAL | $0 |
| Total Assets | $1,349 |
| Liabilities | |
| Current Liabilities | |
| TOTAL | $0 |
| Non-Current Liabilities | |
| TOTAL | $0 |
| Total Liabilities | $0 |
| Shareholders' Equity | |
| Common Shares | 1,536 |
| Retained earnings | -186 |
| TOTAL | $1,349 |
| Total Liabilities And Equity | $1,349 |